CGRP Inhibitors

← Back to Class List

Drug Use Review Documents

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Current Drug Use Criteria New Drug Evaluation
erenumab-aooe AIMOVIG AUTOINJECTOR AUTO INJCT Y PA Document Sep 27, 2018
fremanezumab-vfrm AJOVY AUTOINJECTOR AUTO INJCT Y PA Document  
fremanezumab-vfrm AJOVY SYRINGE SYRINGE Y PA Document  
ubrogepant UBRELVY TABLET Y PA Document  
atogepant QULIPTA TABLET N PA Document  
eptinezumab-jjmr VYEPTI VIAL N PA Document  
galcanezumab-gnlm EMGALITY PEN PEN INJCTR N PA Document  
galcanezumab-gnlm EMGALITY SYRINGE SYRINGE N PA Document  
rimegepant sulfate NURTEC ODT TAB RAPDIS N PA Document  
zavegepant HCl ZAVZPRET SPRAY N PA Document